BDBM582592 WO2023288027, Cmpd 3i(2R,4R)

SMILES CN(C)[C@@H]1C[C@H](c2cccc(c2)-c2ccc(F)cc2)c2ccccc2C1

InChI Key InChIKey=IYRFHZMJBBCIFA-UHFFFAOYSA-N

Data  4 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 582592   

Target5-hydroxytryptamine receptor 2A(Human)
Northeastern University

WIPO
LigandPNGBDBM582592(WO2023288027, Cmpd 3i(2R,4R))
Affinity DataKi:  1.62nMAssay Description:The affinity of ligands was determined via radioligand binding techniques using human recombinant receptors expressed in mammalian clonal cells. Deta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023288027

Target5-hydroxytryptamine receptor 2C(Human)
Northeastern University

WIPO
LigandPNGBDBM582592(WO2023288027, Cmpd 3i(2R,4R))
Affinity DataKi:  30nMAssay Description:The affinity of ligands was determined via radioligand binding techniques using human recombinant receptors expressed in mammalian clonal cells. Deta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023288027

Target5-hydroxytryptamine receptor 2B(Human)
Northeastern University

WIPO
LigandPNGBDBM582592(WO2023288027, Cmpd 3i(2R,4R))
Affinity DataKi:  100nMAssay Description:The affinity of ligands was determined via radioligand binding techniques using human recombinant receptors expressed in mammalian clonal cells. Deta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023288027

TargetHistamine H1 receptor(Human)
Northeastern University

WIPO
LigandPNGBDBM582592(WO2023288027, Cmpd 3i(2R,4R))
Affinity DataKi:  204nMAssay Description:The affinity of ligands was determined via radioligand binding techniques using human recombinant receptors expressed in mammalian clonal cells. Deta...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023288027